U.S. Markets open in 9 hrs 16 mins

Top Ranked Momentum Stocks to Buy for March 7th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 7th:

La-Z-Boy Incorporated (LZB): This furniture products and accessories manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.

La-Z-Boy Incorporated Price and Consensus

La-Z-Boy Incorporated Price and Consensus

La-Z-Boy Incorporated price-consensus-chart | La-Z-Boy Incorporated Quote

La-Z-Boy’s shares gained 14.1% over the last one month against the S&P 500’s rise of 2.4%. The company possesses a Momentum Score of B.

La-Z-Boy Incorporated Price

La-Z-Boy Incorporated Price

La-Z-Boy Incorporated price | La-Z-Boy Incorporated Quote

Genocea Biosciences, Inc. (GNCA): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40.4% over the last 60 days.

Genocea Biosciences, Inc. Price and Consensus

Genocea Biosciences, Inc. Price and Consensus

Genocea Biosciences, Inc. price-consensus-chart | Genocea Biosciences, Inc. Quote

Genocea Biosciences’ shares gained 44.4% over the last one month. The company possesses a Momentum Score of A.

Genocea Biosciences, Inc. Price

Genocea Biosciences, Inc. Price

Genocea Biosciences, Inc. price | Genocea Biosciences, Inc. Quote

KalVista Pharmaceuticals, Inc. (KALV): This pharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.

KalVista Pharmaceuticals, Inc. Price and Consensus

KalVista Pharmaceuticals, Inc. Price and Consensus

KalVista Pharmaceuticals, Inc. price-consensus-chart | KalVista Pharmaceuticals, Inc. Quote

KalVista Pharmaceuticals’ shares gained 16.3% over the last one month. The company possesses a Momentum Score of A.

KalVista Pharmaceuticals, Inc. Price

KalVista Pharmaceuticals, Inc. Price

KalVista Pharmaceuticals, Inc. price | KalVista Pharmaceuticals, Inc. Quote

Ophthotech Corporation (OPHT): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.

Ophthotech Corporation Price and Consensus

Ophthotech Corporation Price and Consensus

Ophthotech Corporation price-consensus-chart | Ophthotech Corporation Quote

Ophthotech’s shares gained 14.4% over the last one month. The company possesses a Momentum Score of B.

Ophthotech Corporation Price

Ophthotech Corporation Price

Ophthotech Corporation price | Ophthotech Corporation Quote

See the full list of top ranked stocks here.

Learn more about the Momentum score and how it is calculated here.

Is Your Investment Advisor Fumbling Your Financial Future?

See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”

Click to get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ophthotech Corporation (OPHT) : Free Stock Analysis Report
 
La-Z-Boy Incorporated (LZB) : Free Stock Analysis Report
 
KalVista Pharmaceuticals, Inc. (KALV) : Free Stock Analysis Report
 
Genocea Biosciences, Inc. (GNCA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.